63
Participants
Start Date
June 11, 2008
Primary Completion Date
December 12, 2010
Study Completion Date
December 19, 2011
PROCHYMAL®
Intravenous infusion of ex vivo cultured adult human mesenchymal stem cells
Placebo
Intravenous infusion of excipients of PROCHYMAL®
Cumberland Valley Endocrinology, Carlisle
The Strelitz Diabetes Center, Eastern VA Medical School, Norfolk
University of North Carolina Diabetes Care Center, Chapel Hill
American Health Research, Inc., Charlotte
University of Florida, Gainesville
Diabetes Research Institute, Miami
University of Alabama, Division of Endocrinology & Metabolism, Birmingham
AM Diabetes & Endocrinology Center, Bartlett
University of Kentucky, Lexington
The Lindner Clinical Trial Center, Cincinnati
Providence Health Partners - Center for Clinical Research, Dayton
Clinical and Transitional Science Institute, Milwaukee
University of Wisconsin Health- West Clinic, Madison
University of Minnesota, Minneapolis
The University of Texas Southwestern Medical Center, Dallas
Optimum Clinical Research, Inc., Salt Lake City
Desert Endocrinology CRC, Henderson
Nevada Alliance Against Diabetes, Las Vegas
Scripps Whittier Diabetes Institute, La Jolla
Stanford University, Stanford
Lead Sponsor
Collaborators (1)
Juvenile Diabetes Research Foundation
OTHER
Mesoblast, Inc.
INDUSTRY